In the News

Connect with us

Stay Informed.
Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
1854 News Items found
The 2024 ASCO sign hangs above a long hallway
Important Findings for Treating Rare Solid Tumors Reported at 2024 ASCO Meeting

Researchers from MSK presented promising studies on treating rare solid tumors including mesothelioma and three types of soft-tissue at the annual meeting of the American Society of Clinical Oncology.
A scientist works at a computer screen with the MSK logo
MSK and NIH Scientists Develop AI Tool to Predict How Cancer Patients Will Respond to Immunotherapy

In a proof-of-concept study, researchers at MSK and the National Institutes of Health (NIH) have developed an artificial intelligence (AI) tool that uses routine clinical data, such as that from a simple blood test, to predict whether someone’s cancer will respond to immune checkpoint inhibitors, a type of immunotherapy drug that helps immune cells kill cancer cells.
Large letters that say ASCO promoting annual meeting in Chicago.
MSK Researchers Present Advances in Lung Cancer Treatment at 2024 ASCO Meeting

Read about advances in lung cancer treatment presented by MSK scientists at the 2024 ASCO meeting.
Susan Everson, a transgender woman, was treated at MSK for stage 3 colorectal cancer. She says her care team made her feel welcome, in addition to offering her the most advanced therapies. Susan is now cancer free.
Being Seen: Compassionate Cancer Treatment for Transgender People

Learn how MSK cares for transgender cancer patients, treating them with respect and medical expertise. Staff are specially trained to understand their needs.
MSK breast medical oncologist Janice Shen.
If You Find a Lump in Your Breast, Here’s What To Do Next

Learn what to do if you find a lump in your breast.
MSK technician Jennifer Moreta helping give a mammogram.
Feature
Common Breast Lumps That Aren’t Cancer

Learn about the different types of benign breast lumps.
An MSK scientist peers through a microscope
MSK Research Highlights, May 24, 2024

New research from MSK investigates a promising approach against diabetic retinopathy and finds patients with early-onset colorectal cancer likely don’t need more frequent surveillance colonoscopies.
GSK master’s degree recipients with members of the platform party
MSK’s 2024 Commencement and Convocation Honors Degree Recipients and Award Winners

At Memorial Sloan Kettering Cancer Center’s 45th annual ceremony, graduating master's and PhD students were honored and award winners were recognized.
Dr. Michael Overholtzer speaks to students.
Meet the 2024 Graduates of the Gerstner Sloan Kettering Graduate School

Ten scientists are poised to receive their PhD degrees from the Gerstner Sloan Kettering Graduate School of Biomedical Sciences. Their years of dedication and training will be recognized on May 15, 2024, as part of Memorial Sloan Kettering’s 45th annual academic convocation.
Detail shot of a nurse holding hands with a patient
MSK Research Highlights, May 10, 2024

New MSK research measures unscheduled healthcare interactions in multiple myeloma patients receiving T cell redirection therapies; investigates oral bacteria’s link to gut microbiota depletion with implications for cancer patients; and shows how a universal opt-out approach could help more cancer patients quit smoking.